« Things I'm Glad I Don't Do: Isolating Ciguatoxin |
| Full Disclosure »
May 3, 2006
Have The Rules Changed?
I'll address this more in tomorrow's post, but everyone should know that there was a potentially very interesting ruling yesterday by the DC Circuit Court of Appeals. Do patients have a right to drugs after Phase I? We might be heading back to the days before efficacy testing was required. . .read this post at Marginal Revolution to get up to speed.
I've spoken about this issue a bit before. Back in 2002 I was very doubtful about the whole idea, but my opinion has been slowly changing. I didn't expect that this is how things would change, but you should never underestimate the courts. More anon.
+ TrackBacks (0) | Category: Drug Development
POST A COMMENT
- RELATED ENTRIES
- Shire's Replagal Problems: An Inside Look?
- Bungled Structure, And How
- Roche Closes Nutley, Once Its US R&D Home
- The Next Five Years in the Drug Industry
- A Kinase Inhibitor Learns Something New
- The Good Ol' Friedel-Crafts
- Merck's Madagascar Marketing Mess
- Scientific Literacy: Where Do You Stop?